{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q6UVK1",
      "entity_text" : "Chondroitin Sulfate Proteoglycan 4",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-1001" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "Ilieva et al. review the potential of antibodies directed to the Chondroitin Sulfate Proteoglycan 4 (CSPG4), overexpressed in several malignant diseases, with apparently restricted and low expression in normal tissues, and examine their direct antiproliferative / metastatic and immune activating mechanisms of action.",
  "reading_complete" : "2020-08-04T11:28:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:28:13Z",
  "trigger" : "overexpressed",
  "evidence" : [ "Chondroitin Sulfate Proteoglycan 4 (CSPG4), overexpressed" ],
  "pmc_id" : "5845095",
  "score" : 0
}